| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-367
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3834
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3633 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06 |
| filingDate |
2009-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9b2a1db0a494818d8cbee4dac5c6c57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_858127c6a21379329567cfbfd1812069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a1fb1f009119f657a632e0e6418c35a |
| publicationDate |
2017-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2628100-T3 |
| titleOfInvention |
Compositions comprising decellularized extracellular matrix obtained from cardiac tissue |
| abstract |
A liquid composition comprising decellularized extracellular matrix derived from cardiac tissue, wherein the composition is suitable for administration through a needle catheter without obstructing the catheter, wherein the decellularized extracellular matrix can be obtained by a method comprising: (a ) processing a sample of cardiac tissue that has an extracellular matrix component and a non-extracellular matrix component to separate the non-extracellular matrix component to obtain decellularized extracellular matrix; (b) lyophilize and pulverize the decellularized extracellular matrix in a powder; (c) produce a composition comprising the extracellular matrix powder decellularized in a liquid; (d) digest the decellularized extracellular matrix in the composition of step (c) with a matrix degrading enzyme at pH 1-6; and (e) neutralizing the pH of the digested decellularized extracellular matrix of step (d) to produce the liquid composition; where the liquid composition becomes a gel at body temperature. |
| priorityDate |
2008-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |